<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>24(1)</volume><submitter>Sagard J</submitter><funding>Alfred Österlunds Stiftelse</funding><funding>Stiftelsen Professor Nanna Svartz Fond</funding><funding>Grants from the Swedish government to researchers in public health care</funding><funding>Reumatikerförbundet</funding><funding>Skånes universitetssjukhus</funding><funding>Kock Foundation</funding><funding>Anna-Greta Crafoords stiftelse</funding><funding>Hedlund Foundation</funding><funding>Lundgren Foundation</funding><funding>Lund University</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>Based on clinical and genetic associations, axial spondyloarthritis (axSpA) and inflammatory bowel disease (IBD) are suspected to have a linked pathogenesis. Gut dysbiosis, intrinsic to IBD, has also been observed in axSpA. It is, however, not established to what degree gut dysbiosis is associated with axSpA disease severity. The objective of this study was to compare gut dysbiosis frequency between controls, non-radiographic axial spondyloarthritis (nr-axSpA), and ankylosing spondylitis (AS) patients and investigate whether gut dysbiosis is cross-sectionally associated with axSpA disease activity, physical function, mobility, or pain.&lt;h4>Methods&lt;/h4>Gut dysbiosis was assessed by 16SrRNA analysis of feces from 44/88 nr-axSpA/AS patients (ASAS/mNY criteria) without inflam</pubmed_abstract><journal>Arthritis research &amp; therapy</journal><pagination>42</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8840679</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.</pubmed_title><pmcid>PMC8840679</pmcid><pubmed_authors>Geijer M</pubmed_authors><pubmed_authors>Andreasson K</pubmed_authors><pubmed_authors>Kristensen LE</pubmed_authors><pubmed_authors>Sagard J</pubmed_authors><pubmed_authors>Olofsson T</pubmed_authors><pubmed_authors>Marsal J</pubmed_authors><pubmed_authors>Lindqvist E</pubmed_authors><pubmed_authors>Wallman JK</pubmed_authors><pubmed_authors>Mogard E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.</name><description>&lt;h4>Background&lt;/h4>Based on clinical and genetic associations, axial spondyloarthritis (axSpA) and inflammatory bowel disease (IBD) are suspected to have a linked pathogenesis. Gut dysbiosis, intrinsic to IBD, has also been observed in axSpA. It is, however, not established to what degree gut dysbiosis is associated with axSpA disease severity. The objective of this study was to compare gut dysbiosis frequency between controls, non-radiographic axial spondyloarthritis (nr-axSpA), and ankylosing spondylitis (AS) patients and investigate whether gut dysbiosis is cross-sectionally associated with axSpA disease activity, physical function, mobility, or pain.&lt;h4>Methods&lt;/h4>Gut dysbiosis was assessed by 16SrRNA analysis of feces from 44/88 nr-axSpA/AS patients (ASAS/mNY criteria) without inflam</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-06-03T10:25:04.813Z</modification><creation>2025-04-06T15:51:20.463Z</creation></dates><accession>S-EPMC8840679</accession><cross_references><pubmed>35151357</pubmed><doi>10.1186/s13075-022-02733-w</doi></cross_references></HashMap>